Promethera Biosciences Competitors and Similar CompaniesClear all

Intercept Pharmaceuticals's competitors and similar companies include Poxel and Pfizer.

	Intercept Pharmaceuticals Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases.	Poxel Poxelis a research integrated pharmaceutical company that develops products for metabolic diseases.	Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
Founding Date	Founding Date 2002	Founding Date 2009	Founding Date 1849
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare Technology	Tags Healthcare biotech clinical research drug development pharma
Locations	Locations New York, US HQ Wien, AT Mississauga, CA Kongens Lyngby, DK Paris, FR München, DE Dublin, IE see more	Locations Lyon, FR HQ Chiyoda City, JP Cambridge, US	Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more
Employees	Employees 58321% increase	Employees 6	Employees 81,0008% decrease
Valuation ($)	Valuation ($) 794.7 m	Valuation ($) 18.3 m	Valuation ($) 163.9 b
Financial
Revenue (est.)	Revenue (est.) $285.7m (FY, 2022)	Revenue (est.) €6.6m (FY, 2024)	Revenue (est.) $62.6b (FY, 2025)
Cost of goods	Cost of goods $984k (FY, 2022)	Cost of goods €2.8m (FY, 2024)	Cost of goods $16.1b (FY, 2025)
Gross profit	Gross profit $284.7m (FY, 2022)	Gross profit €3.8m (FY, 2024)	Gross profit $46.5b (FY, 2025)
Net income	Net income $221.8m (FY, 2022)	Net income (€18.3m) (FY, 2024)	Net income $7.8b (FY, 2025)
Funding
Total funding raised	Total funding raised $ 55m	Total funding raised $ 33.8m	Total funding raised N/A